MetaStat, Inc. (MTST)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0842 (-99.76%)
At close: Aug 7, 2025
MetaStat Revenue
In the fiscal year ending February 28, 2018, MetaStat had annual revenue of $23.30K.
Revenue
23.30K
Revenue Growth
n/a
P/S Ratio
0.05
Revenue / Employee
3.88K
Employees
6
Market Cap
1.18K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2018 | 23.30K | - | - |
| Feb 28, 2017 | - | - | - |
| Feb 29, 2016 | - | - | - |
| Feb 28, 2015 | - | - | - |
| Feb 28, 2014 | - | - | - |
| Feb 28, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |